 | • レポートコード：STR-DC002 • 出版社/出版日：Straits Research / 2019年11月28日 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名様用、印刷不可） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Multi User（5名様用） | ￥836,200 (USD5,650) | ▷ お問い合わせ |
| Enterprise Price（法人閲覧用） | ￥1,073,000 (USD7,250) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートでは、急性脊髄損傷の世界市場について調査・分析し、調査手法、市場概要、種類別（診断、治療）分析、診断種類別（臨床検査、画像検査）分析、エンドユーザー別（病院＆診療所、外来センター、その他）分析、地域別分析、企業概要などを含め次の構成でお届け致します。 ・イントロダクション ・調査手法 ・市場概要 ・急性脊髄損傷の世界市場：種類別（診断、治療） ・急性脊髄損傷の世界市場：診断種類別（臨床検査、画像検査） ・急性脊髄損傷の世界市場：エンドユーザー別（病院＆診療所、外来センター、その他） ・急性脊髄損傷の世界市場：地域別 ・企業概要 |
Global acute spinal cord injury market was valued at USD 5,121 million in 2018, growing at a CAGR of 4.1% during the forecast period of 2019–2026.
Spinal cord injuries are the most medically complex and associated with high mortality rate. Many factors can cause these injuries such as accident, fall, violent incidence, and sudden shock or cut to spine, among others. It has been estimated that over 500,000 people suffer from spinal cord injuries (SCI) every year across the globe. Increasing FDI and shifting automobile industry in developing countries have fulfilled the dream of having a vehicle of the middle-class population. Countries like Brazil, China, and India are witnessing tremendous opportunities from the multinational and domestic automobile industry. However, automobile accidents are identified as the most common cause for spinal cord injuries. For instance, automobile accidents, falls, violence such as gunshot wounds, sport accidents, medical/surgical, and others accounted for 38.5%, 31.7%, 13.7%, 8.1%, 4.4%, and 4% respectively of all the spinal cord injuries in the U.S during 2015–2018, according to the National Spinal Cord Injury Statistical Center.
Research on Neuromodulation Therapies, blessing for spinal cord injuries?
Neuromodulation therapies are expected to emerge as one of the most futuristic developments in the spinal cord injury research. It has been found that neuropathic pain is the most severe problem for people having spinal cord injuries. However, stimulation is a cost-effective solution, and can also provide long term health benefits to patients along with reduced complications of the procedure. On account these benefits, spinal cord stimulation is gaining pace in the Europe and the U.S. market. For instance, in 2016, a patient underwent successful surgery at Ohio State’s Center for Neuromodulation and doctors could successfully implant a chip in his brain. The chip was configured to read brain signals and communicate through a computer on patient’s sleeve. As a result, the patient could move his hands easily.
Segmental Insights
For a better understanding of the global acute spinal cord injury market, we have segmented the market by type, diagnosis type and end user.
By type, the market is segmented into diagnosis and treatment. Treatment is accounting for the major market share. By diagnosis type, the market is divided into laboratory tests and imaging tests. Laboratory tests are expected to grow at a CAGR of 6.2%. Moreover, Imaging is highly adopted in the developing and developed regions due to its high efficiency and precision in detecting the blood clots and other injuries in the spinal cord. Ongoing technological advancements in the imaging techniques and devices, increasing disposable income in the developing countries, and a growing number of diagnostic imaging centers in the developing regions such as Asia Pacific and the Middle East are projected to fuel the demand in the coming years.
Regional Insights
Global acute spinal cord injury market by Americas, Asia Pacific, Europe, and the Middle East and Africa.
North America is dominating the market and accounted for the highest share in the forecast period. Road accident is the leading cause of spinal cord injury in the U.S. Over 17,700 new cases of SCI occur every year. Automobile accidents are the most common cause for spinal cord injury in the U.S. in addition, several other factors can also lead to spinal cord injury. For instance, automobile accidents, falls, violence such as gunshot wounds, sport accidents, medical/surgical, and others accounted for 38.5%, 31.7%, 13.7%, 8.1%, 4.4%, and 4% respectively in the U.S during 2015–2018, according to the National Spinal Cord Injury Statistical Center. Moreover, growing aging population, which is prone to fall, and accidents also have high chances of developing SCI. In addition, many government and non-profit organizations are working towards betterment of patients. For instance, the North American Spinal Cord Injury Consortium organization supports the spinal cord injury community in terms of research, care, and cure.
Europe is second leading region in the forecast period owing to higher healthcare spending. around 10,000 incidences of spinal cord injury are reported every year in EU, the European Spinal Cord Injury Federation. With the high disposable income and strong insurance coverage, people are increasingly spending on healthcare to receive quality treatment. European countries spend a huge amount on healthcare facilities. In 2016, health care expenditure, as a percentage of GDP, was highest in France 11.5%, followed by Germany 11.1 %, and Sweden 10.9 %, Eurostat.
Middle East & Africa is offering various lucrative opportunities for the market. Acute Spinal Cord Injury in Africa is one of the economically valuable sectors, as it helps in creating sustainable employment in the region. Ethiopia, Kenya, and Tanzania are the largest honey producers in the region and have a high demand from large markets like Nigeria and South Africa. Beeswax and Propolis are some other major products, which are widely used in skin care and cosmetic, shoe, furniture, and candle manufacturing industries. Additionally, Acute Spinal Cord Injury has great potential in bringing economic development to Africa and help in reducing poverty in the region. In Kenya, it is lucrative and generates a significant income, and approximately 70% of youth and 50% of women are involved in it. Low investment in beekeeping and no requirement of land are the major factors attracting youth to adopt it in a more professional manner.
Key Players
Some of the prominent players in the market are Histocell, Mitsubishi Tanabe Pharma Corporation, Neuralstem, Inc., Acorda Therapeutics, Inc., Pfizer, BioAxone, BIOTIME, INC.
TABLE OF CONTENTS
1 Introduction
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources
3 Market Overview
3.1 Report Segmentation & Scope
3.2 Value Chain Analysis: Acute Spinal Cord Injury Market
3.3 Key Market Trends
3.3.1 Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitution
3.4.4 Threat of New Entrants
3.4.5 Competitive Rivalry
3.5 Market Share Analysis
4 Type Overview
4.1 Introduction
4.1.1 Market Size & Forecast
4.2 Diagnosis
4.3 Treatment
5 Diagnosis Type Overview
5.1 Introduction
5.1.1 Market Size & Forecast
5.2 Laboratory Tests
5.3 Imaging Tests
6 End User Overview
6.1 Introduction
6.1.1 Market Size & Forecast
6.2 Hospitals & Clinics
6.3 Ambulatory centers
6.4 Others
7 Regional Overview
7.1 Introduction
7.1.1 Market Size & Forecast
7.2 America
7.2.1 North America
7.2.1.1 U.S.
7.2.1.1.1 By Type
7.2.1.1.2 By Diagnosis Type
7.2.1.1.3 By End User
7.2.1.2 Canada
7.2.1.2.1 By Type
7.2.1.2.2 By Diagnosis Type
7.2.1.2.3 By End User
7.2.1.3 Mexico
7.2.1.3.1 By Type
7.2.1.3.2 By Diagnosis Type
7.2.1.3.3 By End User
7.2.2 South America
7.2.2.1 By Type
7.2.2.2 By Diagnosis Type
7.2.2.3 By End User
7.3 Europe
7.3.1 Market Size & Forecast (Value)
7.3.2 Western Europe
7.3.2.1 Germany
7.3.2.1.1 By Type
7.3.2.1.2 By Diagnosis Type
7.3.2.1.3 By End User
7.3.2.2 France
7.3.2.2.1 By Type
7.3.2.2.2 By Diagnosis Type
7.3.2.2.3 By End User
7.3.2.3 U.K.
7.3.2.3.1 By Type
7.3.2.3.2 By Diagnosis Type
7.3.2.3.3 By End User
7.3.2.4 Italy
7.3.2.4.1 By Type
7.3.2.4.2 By Diagnosis Type
7.3.2.4.3 By End User
7.3.2.5 Spain
7.3.2.5.1 By Type
7.3.2.5.2 By Diagnosis Type
7.3.2.5.3 By End User
7.3.2.6 Rest of Western Europe
7.3.2.6.1 By Type
7.3.2.6.2 By Diagnosis Type
7.3.2.6.3 By End User
7.3.3 Eastern Europe
7.4 Asia Pacific
7.4.1 Market Size & Forecast (Value)
7.4.2 China
7.4.2.1 By Type
7.4.2.2 By Diagnosis Type
7.4.2.3 By End User
7.4.3 India
7.4.3.1 By Type
7.4.3.2 By Diagnosis Type
7.4.3.3 By End User
7.4.4 Japan
7.4.4.1 By Type
7.4.4.2 By Diagnosis Type
7.4.4.3 By End User
7.4.5 South Korea
7.4.5.1 By Type
7.4.5.2 By Diagnosis Type
7.4.5.3 By End User
7.4.6 Australia
7.4.6.1 By Type
7.4.6.2 By Diagnosis Type
7.4.6.3 By End User
7.4.7 Rest of Asia-Pacific
7.4.7.1 By Type
7.4.7.2 By Diagnosis Type
7.4.7.3 By End User
7.5 Middle East
7.5.1 Market Size & Forecast (Value)
7.5.2 The Middle East
7.5.2.1 UAE
7.5.2.2.1 By Type
7.5.2.2.2 By Diagnosis Type
7.5.2.2.3 By End User
7.5.2.2 Qatar
7.5.2.2.1 By Type
7.5.2.2.2 By Diagnosis Type
7.5.2.2.3 By End User
7.5.2.3 Rest of Middle East
7.5.2.3.1 By Type
7.5.2.3 2 By Diagnosis Type
7.5.2.3 3 By End User
7.6 Africa
7.6.1 Market Size & Forecast (Value)
7.6.2 South Africa
7.6.2.1 South Africa
7.6.2.1.1 By Type
7.6.2.1.2 By Diagnosis Type
7.6.2.1.3 By End User
7.6.2.2 Ghana
7.6.2.2.1 By Type
7.6.2.2.2 By Diagnosis Type
7.6.2.2.3 By End User
7.6.2.3 Nigeria
7.6.2.3.1 By Type
7.6.2.3.2 By Diagnosis Type
7.6.2.3.3 By End User
7.6.2.4 Rest of Africa
7.6.2.4.1 By Type
7.6.2.4 2 By Diagnosis Type
7.6.2.4.3 By End User
8. Company Profile
8.1 Histocell
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Recent Developments
8.1.4 Product Portfolio
8.2 Mitsubishi Tanabe Pharma Corporation
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Recent Developments
8.2.4 Product Portfolio
8.3 Neuralstem, Inc.
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Recent Developments
8.3.4 Product Portfolio
8.4 Acorda Therapeutics, Inc.
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Recent Developments
8.4.4 Product Portfolio
8.5 Pfizer
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Recent Developments
8.5.4 Product Portfolio
8.6 BioAxone
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Recent Developments
8.6.4 Product Portfolio
8.7 BIOTIME, INC.
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Recent Developments
8.7.4 Product Portfolio
TABLE 1 Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 2 Diagnosis Acute Spinal Cord Injury Market Share, By Region, 2016-2026 ($ Million)
TABLE 3 Treatment Acute Spinal Cord Injury Market Share, By Region, 2016-2026, ($ Million)
TABLE 4 Acute Spinal Cord Injury Market Share Value, 2016-2026 ($Million)
TABLE 5 Acute Spinal Cord Injury Market Share, By Region, 2016-2026 ($ Million)
TABLE 6 America Acute Spinal Cord Injury Market Share Value, By Region, 2016-2026 ($Million)
TABLE 7 America Acute Spinal Cord Injury Market Share value, By Type, 2016-2026 ($Million)
TABLE 8 America Acute Spinal Cord Injury Market Share value, By End User, 2016-2026 ($Million)
TABLE 9 U.S. Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 10 U.S. Acute Spinal Cord Injury Market Share, By End User, 2016-2026 ($Million)
TABLE 11 Canada Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 12 Canada Acute Spinal Cord Injury Market Share, By End User 2016-2026 ($Million)
TABLE 13 Mexico Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 14 Mexico Acute Spinal Cord Injury Market Share, By End User 2016-2026 ($Million)
TABLE 15 South America Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 16 South America Acute Spinal Cord Injury Market Share, By End User 2016-2026 ($Million)
TABLE 17 Europe Acute Spinal Cord Injury Market Share Value, By Region, 2016-2026 ($Million)
TABLE 18 Europe Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 19 Europe Acute Spinal Cord Injury Market Share, By End User 2016-2026 ($Million)
TABLE 20 Western Europe Acute Spinal Cord Injury Market Share Value, By Country, 2016-2026 ($Million)
TABLE 21 Western Europe Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 22 Western Europe Acute Spinal Cord Injury Market Share, By End User 2016-2026 ($Million)
TABLE 23 Germany Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 24 Germany Acute Spinal Cord Injury Market Share, By End User 2016-2026 ($Million)
TABLE 25 France Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 26 France Acute Spinal Cord Injury Market Share, By End User 2016-2026 ($Million)
TABLE 27 UK Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 28 UK Acute Spinal Cord Injury Market Share, By End User 2016-2026 ($Million)
TABLE 29 Italy Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 30 Italy Acute Spinal Cord Injury Market Share, By End User 2016-2026 ($Million)
TABLE 31 Spain Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 32 Spain Acute Spinal Cord Injury Market Share, By End User, 2016-2026 ($Million)
TABLE 33 Rest of Western Europe Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 34 Rest of Western Europe Acute Spinal Cord Injury Market Share, By End User, 2016-2026 ($Million)
TABLE 35 Eastern Europe Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 36 Eastern Europe Acute Spinal Cord Injury Market Share, By End User 2016-2026 ($Million)
TABLE 37 Asia-Pacific Acute Spinal Cord Injury Market Share, By Country, 2016-2026 ($Million)
TABLE 38 Asia-Pacific Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 39 Asia-Pacific Acute Spinal Cord Injury Market Share, By End User, 2016-2026 ($Million)
TABLE 40 Japan Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 41 Japan Acute Spinal Cord Injury Market Share, By End User, 2016-2026 ($Million)
TABLE 42 China Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 43 China Acute Spinal Cord Injury Market Share, By End User, 2016-2026 ($Million)
TABLE 44 Australia Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 45 Australia Acute Spinal Cord Injury Market Share, By End User, 2016-2026 ($Million)
TABLE 46 India Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 47 India Acute Spinal Cord Injury Market Share, By End User, 2016-2026 ($Million)
TABLE 48 South Korea Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 49 South Korea Acute Spinal Cord Injury Market Share, By End User 2016-2026 ($Million)
TABLE 50 Rest of Asia-pacific Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 51 Rest of Asia-pacific Acute Spinal Cord Injury Market Share, By End User, 2016-2026 ($Million)
TABLE 52 The Middle East and Africa Acute Spinal Cord Injury Market Share, By Region, 2016-2026 ($Million)
TABLE 53 The Middle East and Africa Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 54 The Middle East and Africa Acute Spinal Cord Injury Market Share, By End User, 2016-2026 ($Million)
TABLE 55 The Middle East Acute Spinal Cord Injury Market Share, By Country, 2016-2026 ($Million)
TABLE 56 The Middle East Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 57 The Middle East Acute Spinal Cord Injury Market Share, By End User, 2016-2026 ($Million)
TABLE 58 Saudi Arabia Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 59 Saudi Arabia Acute Spinal Cord Injury Market Share, By End User, 2016-2026 ($Million)
TABLE 60 UAE Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 61 UAE Acute Spinal Cord Injury Market Share, By End User, 2016-2026 ($Million)
TABLE 62 Qatar Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 63 Qatar Acute Spinal Cord Injury Market Share, By End User, 2016-2026 ($Million)
TABLE 64 Africa Acute Spinal Cord Injury Market Share, By Country, 2016-2026 ($Million)
TABLE 65 Africa Acute Spinal Cord Injury Market Share, By Type, 2016-2026 ($Million)
TABLE 66 Africa Acute Spinal Cord Injury Market Share, By End User, 2016-2026 ($Million)
List of Figures
FIGURE 1 Acute Spinal Cord Injury Market Overview
FIGURE 2 Value Chain Analysis
FIGURE 3 Bargaining Power of Suppliers
FIGURE 4 Bargaining Power of Buyers
FIGURE 5 Threat of Substitutes
FIGURE 6 Threat of New Entrants
FIGURE 7 Competitive Rivalry
FIGURE 8 Acute Spinal Cord Injury Market, 2016-2026
FIGURE 9 U.S. Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 10 Canada Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 11 Mexico Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 12 South America Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 13 Western Europe Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 14 Germany Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 15 France Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 16 UK Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 17 Italy Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 18 Spain Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 19 Rest of Western Europe Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 20 Eastern Europe Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 21 Japan Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 22 China Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 23 Australia Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 24 India Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 25 South Korea Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 26 Rest of Asia-pacific Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 27 The Middle East Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 28 Saudi Arabia Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 29 UAE Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 30 Qatar Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 31 Rest of The Middle East Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 32 Africa Acute Spinal Cord Injury Market Share, 2016-2026 ($Million)
FIGURE 33 Mitsubishi Tanabe Pharma Corporation: Revenue Analysis, ($ million)
FIGURE 34 Mitsubishi Tanabe Pharma Corporation: Segment Revenue 2018 (%)